BACKGROUND : Osteoarthritis (OA) is a prevalent and debilitating condition aff ecting over 20% of the population aged > 50 years.
Outcome measured Success Evidence Harms
Comparing Tramadol given alone with placebo:
For pain
For physical function
There was a mean reduction in pain in the tramadol group (on a 1100 scale Tramadol decreased the pain by 4 points ±1). This reduction would not be large enough to make a clinical difference to the patient.
There was a mean improvement in physical function of 4% (2-6%). This improvement would not be large enough to make a clinical difference to the patient.
This evidence is of moderate quality and is based on 3972 participants from eight studies.
This evidence is of moderate quality and is based on 2550 participants from fi ve studies.
Tramadol caused signifi cantly more side effects than placebo or NSAIDS. More participants randomised to Tramadol withdrew from the trials than those on placebo or taking NSAIDS.
Comparing Tramadol given alone with acetaminophen: For pain
There was no difference in pain between the groups This evidence is of very low quality and is based on 20 participants from one study.
Comparing Tramadol given alone with NSAIDs:
For pain NSAIDS were more effective as a pain reliever (on a 1-100 scale Tramadol was 22 points higher (CI 7-37) than NSAIDS).
This evidence is of moderate quality and is based on 952 participants from three studies For physical function NSAIDS were more effective for increasing physical function (on a 0-1700 scale Tramadol was 82 points higher (CI 32-131) than NSAIDS).
This evidence is of low quality and is based on 952 participants from three studies
